Table 1.
Demographic, historical and clinical characteristics of patients with PD at baseline
| Mean (SD) | ||
|---|---|---|
|
| ||
| Age at baseline (years) | 70.8 (9.1) | |
| Age at symptomatic PD onset (years) | 64.5 (10.5) | |
| Follow-up from initial visit (years) | 3.9 (3.1) | |
| Follow-up from symptomatic PD onset (years) | 10.3 (6.1) | |
| Modified UPDRS motor score | 30.2 (14.6) | |
| H&Y stage | 2,3 | |
| LED (mg/day) | 526.2 (343.9) | |
|
| ||
| N (%) | ||
|
| ||
| Patients on antiparkinsonian medication | 421 (62) | |
| Gender | ||
| Female | 221 (32) | |
| Male | 464 (68) | |
| Handedness | ||
| Right | 627 (91) | |
| Left | 45 (7) | |
| Ambidextrous | 13 (2) | |
| History of depression | ||
| No | 457 (67) | |
| Yes | 228 (33) | |
| Family history of PD | ||
| No | 581 (85) | |
| Yes | 104 (15) | |
| Family history of AD | ||
| No | 638 (93) | |
| Yes | 47 (7) | |
| Family history of MND | ||
| No | 680 (99) | |
| Yes | 5 (1) | |
| Family history of other MD / NDD | ||
| No | 637 (93) | |
| Yes | 48 (7) | |
PD=Parkinson Disease; UPDRS=Unified Parkinson Disease Rating Scale; H&Y=Hoehn and Yahr Scale; LED=Levodopa Equivalent Dose; MD=Movement Disorder; NDD=Neurodegenerative Disorder; AD=Alzheimer Disease; MND=Motor Neuron Disease; SD=Standard Deviation